According to the World Health Organization, 24% of the global disease burden and 23% of all deaths are attributable to environmental factors (1) . The causal pathway from exposure to disease and death is often complex and poorly understood. These risks are not evenly distributed across all age groups. Children may be particularly susceptible to the adverse environmental effects, as the proportion of deaths among children attributed to the environment is as high as 36% (1) .
While there is a large literature linking ambient air pollution and cardiopulmonary disease (2) (3) (4) (5) (6) , less is known about the impact of indoor air pollution on morbidity and mortality. Children, the elderly, and women are the most vulnerable with respect to potential indoor air pollution health effects because they spend more time in the home environment. Time activity studies have estimated that children and the elderly can spend as much as 90% of their time indoors (7) . This observation underscores the substantial contribution that indoor exposures can make to an individual's total exposure.
There are many sources of indoor air pollution in the home environment. Air pollution inside homes consists of a complex mixture of agents penetrating from ambient (outdoor) air and agents generated by indoor sources. Indoor pollutants can vary in their potential health effects and intensity, as well as in their distribution across geographic areas, cultural backgrounds, and socioeconomic status. Indoor pollutants include products of combustion, including particulate matter (PM) and oxides of nitrogen, as well as airborne allergens and endotoxin. Exposure to indoor air pollutants can cause health effects ranging from sneezing and coughing to outcomes such as cancer and exacerbation of chronic respiratory disorders such as asthma.
Asthma, a complex disease influenced by both environmental and genetic factors, is common and the prevalence is increasing worldwide (8) . Childhood asthma is the most common chronic disease in children. The International Study of Asthma and Allergies in Childhood (ISAAC) estimates the asthma prevalence by country as ranging from 2% to 40% (9) . Indoor environmental factors thought to modify asthma severity include pollutants such as PM, nitrogen oxides, secondhand smoke, and allergens from pests, pets, and molds (10) . In contrast to the outdoor environments, people may have a greater ability to modify indoor environmental exposures. The ability to modify indoor environments makes addressing indoor air pollution an attractive target for disease prevention.
The purpose of this article is to present an overview of research on indoor pollution and asthma focusing on studies conducted by the Johns Hopkins Center for Childhood Asthma in the Urban Environment.
INDOOR PARTICULATE MATTER
Particulate matter is a principal component of indoor air pollution in homes. PM originates from a variety of humanmade and natural sources. Natural sources include pollen, spores, bacteria, plant and animal debris, and suspended crustal materials. Human-made sources consist of industrial emissions and combustion by-products from incinerators, motor vehicles, and power plants. Indoor sources include cigarette smoking, cooking, wood and other biomass burning in stoves and fireplaces, cleaning activities that re-suspend dust particles (e.g., sweeping), and penetration of outdoor particles into the indoor environment (11, 12) . Indoor PM differs from outdoor PM in source, composition, and concentration (11, (13) (14) (15) (16) . As a result, the health effects of indoor PM cannot be readily extrapolated from studies of outdoor air pollution. Figure 1 presents the timedependent PM concentrations determined using a light scattering nephelometer (MIE pDR 1000; ThermoElectron, Franklin, MA) measured simultaneously inside a home, immediately outside the home, and at a central monitoring site. In this instance, PM measured inside the home is clearly higher and more variable than outside either at the home or a central monitoring site, demonstrating the importance and complexity of addressing the health effects of indoor airborne particles.
There are relatively few studies of indoor PM and asthma. Studies of school-age children in Seattle found that indoor PM 2.5 exposure was associated with decreased pulmonary function in a subgroup of 10 children not using inhaled corticosteroids (17) . In this study, Koenig and coworkers (17) also found that PM 2.5 originating from indoor sources was more potent in decreasing lung function than was outdoor-derived PM. A California study of 19 predominantly white children found significant decrements in lung function (FEV 1 ) associated with indoor PM. While this study found associations between ambient PM and lung function, they found stronger associations for indoor than outdoor central site PM concentrations (18) .
A longitudinal study of 150 inner city preschool children with asthma, conducted as a part of the Johns Hopkins Center Significant determinants of indoor PM concentrations included smoking, sweeping, and stove use (19) , activities that are modifiable and provide opportunities for exposure reduction. Smoking has been consistently described as a major source of indoor particulates over the last several decades, with more than 30% of all U.S. children exposed to secondhand smoke (20) . Our results suggest that smoking continues to be a significant contributor to PM exposure in the inner city. The difference in PM 2.5 between smoking and nonsmoking households of 26 mg/m 3 is similar to the range of 25 to 45 mg/m 3 that has been previously reported (11, 16, 21, 22) .
Indoor coarse PM concentrations were associated with substantial increases in asthma symptoms (Figure 3 ). For example, for every 10-mg/m 3 increase in indoor PM 2.5-10 concentration, there was a 6% increase in the number of days of cough, wheeze, or chest tightness, after adjusting for age, race, sex, socioeconomic status, season, indoor fine PM, and ambient fine and coarse PM concentrations. In adjusted models, higher indoor coarse PM concentration was also significantly associated with increased incidence of symptoms severe enough to slow a child's activity, wheezing that limited speaking ability, nocturnal symptoms, and rescue medication use. Outdoor coarse PM was not associated with increased asthma symptoms or rescue medication use.
Fine PM was also positively associated with respiratory symptoms and with rescue medication use (Figure 3 ). For example, for every 10-mg/m 3 increase in PM 2.5 measured indoors, there was a 7% increase in days of wheezing severe enough to limit speech and a 4% increase in days on which rescue medication was needed, after adjustment for potential confounders. Both indoor and ambient fine PM concentrations were also associated with exercise-related respiratory symptoms. In multivariate models adjusting for participant characteristics that were potential confounders as well as for simultaneous indoor and ambient coarse PM, for every 10-mg/m 3 increase in indoor and ambient PM 2.5 , there was a 7% and a 26% (data on ambient PM not shown in Figure 3 ) increase in days of exercise-related symptoms, respectively. In contrast, neither indoor nor ambient coarse PM concentrations were associated with exercise-related symptoms.
These findings demonstrate that both indoor coarse and fine PM distinctly affect respiratory health in children with asthma. There are physiologic reasons that can explain why PM of these different size fractions can contribute separately to asthma morbidity. Although fine PM may be capable of reaching the alveoli, the regions responsible for gas exchange, the deposition of coarse PM in upper airways and subsequent bronchial hyperreactivity may be responsible for the symptomatic response measured in these preschool children.
The strong relationship between indoor and ambient fine PM exposure and exercise-related symptoms was striking in this study. Previous investigators have indicated that exercise may play a role in asthma by modifying the effect of environmental stimuli and pollutants (18) . Increased exercise symptoms in response to fine PM exposure may be attributable to increased minute ventilation and an increased dose of fine PM in the distal airways and the pulmonary circulation. The increased fine PM doses in the distal airways may be more potent in eliciting exercise-related symptoms than the doses of coarse PM that deposit in the more proximal airways.
INDOOR NITROGEN DIOXIDE AND ASTHMA MORBIDITY
Nitrogen dioxide is a product of high-temperature combustion. The principal indoor source of NO 2 is unvented gas appliances (stoves and furnaces). NO 2 may be particularly problematic in the inner city, where gas stoves are common and proper venting rare and using stoves for heating is commonly reported. Results from the BIESAK Study have demonstrated high indoor NO 2 concentrations in inner city Baltimore homes (21, 23) .
NO 2 is an irritant gas and has been linked to respiratory effects. Although some studies (24) (25) (26) (27) (28) (29) have found adverse respiratory health effects from indoor NO 2 , other studies have failed to confirm that association (30) (31) (32) (33) (34) . For example, data from the National Health and Nutrition Examination Survey III did not suggest any impact from gas stoves on pulmonary function or respiratory symptoms in adults with asthma (34) . In contrast, the National Cooperative Inner City Asthma Study (NCICAS) conducted in eight inner cities across the United States showed a link between higher concentrations of indoor NO 2 and increased symptoms and decreased peak flows in children with asthma (35) .
Hansel and colleagues (36) recently reported on the effect of indoor NO 2 concentrations and asthma in the BIESAK longitudinal cohort. Most of the homes in the BIESAK study were row homes (homes that share adjacent walls; 79%) and close to the street (within 25 ft; 71%). The overall mean (6 SD) indoor NO 2 concentration was 30.0 6 33.7 ppb (range, 2.9-394.0 ppb). NO 2 concentrations were significantly lower in summer (15.9 6 14.0 ppb) than in any other season. The mean ambient NO 2 concentration during the study period was 25.7 ppb, and there was minimal correlation (r 2 5 0.056, P , 0.01) between ambient and indoor NO 2 concentrations. NO 2 concentrations were higher in homes with a gas stove (mean, 33.1 ppb) compared with those without a gas stove (mean, 16.8 ppb). Similarly, the mean indoor NO 2 concentrations were 7.2 ppb higher in homes with a gas heater compared with those without a gas heater, and the presence of a gas heater had a greater effect on indoor NO 2 concentrations during the winter months.
As summarized in Figure 4 , higher NO 2 concentrations were associated with statistically significant increases in respiratory symptoms in preschool children with asthma. After adjusting for potential confounders, increasing NO 2 concentrations were significantly associated with increasing frequency of limited speech due to wheezing, coughing without a cold, and nocturnal awakenings due to cough, wheeze, and shortness of breath or chest tightness during the daytime and while running. There was no significant relationship between NO 2 concentration and rescue medication use in the previous two weeks or health care utilization. In general, the presence of atopy did not modify the effect of NO 2 exposure on asthma symptoms, except that individuals with atopy were more likely to experience nocturnal symptoms with increasing NO 2 concentration (Incidence Rate Ratio [IRR] 5 1.13 per 20-ppb increase in NO 2 ) compared with nonatopic individuals (IRR 5 1.03). In addition, daily use of inhaled corticosteroids (ICS) did not modify the association of NO 2 concentrations and asthma symptoms, and mean ambient NO 2 concentrations were not significantly associated with any respiratory symptoms.
MOUSE ALLERGEN AND ASTHMA
Asthma is an allergic and inflammatory disease, and exposure to indoor allergens is a widely recognized risk factor for asthma morbidity (37). Allergens can be produced from pests (mites, cockroaches, rodents), pets (cats, dogs), plants (pollen), and fungi (mold spores). Allergens as risk factors for asthma have been widely studied (38, 39) . Mouse allergen, a well-recognized occupational allergen, has only recently been identified as a common household allergen. Matsui and coworkers investigated the role of mouse allergen exposure in the BIESAK cohort and other homes in Baltimore, MD (39, 40) , reporting that 100% of homes in inner city Baltimore had detectable mouse allergen in settled dust samples. In addition, airborne mouse allergen was detected in greater than 80% of the bedrooms sampled. Settled dust concentrations of mouse allergen that exceeded 0.5 mg/g were found to be predictive of having detectable airborne mouse allergen (39) .
In the BIESAK cohort, both asthma symptoms and asthmarelated health care use were more common among mousesensitized participants who had greater than 0.5mg/g of mouse allergen in their bedroom dust sample than in the others (Figures 5 and 6 ). The associations between mouse allergen exposure and asthma outcomes were found to be independent of cockroach sensitization/exposure, public health insurance, atopy, age, and sex.
CONCLUSIONS
Analyses of exposure outcome relationships in the BIESAK cohort and other studies mentioned in this review demonstrate the importance of evaluating indoor home air pollution sources as risk factors for asthma morbidity. Results presented indicate that indoor particulate matter (particularly the coarse fraction), NO 2 , and mouse allergen exposure are important determinants of asthma morbidity in urban environments.
Avoidance of harmful exposures is a key component of national and international guideline recommendations for management of asthma (41, 42) . Guidelines identify PM and NO 2 as pollutants of concern, but specific recommendations are limited and focused mostly on avoiding exposure to elevated outdoor concentrations. Objective measure of indoor air exposures may be indicated for children with uncontrolled asthma. These results from the BIESAK and other studies suggest that modifying the indoor environment to reduce PM, NO 2 , and mouse allergen may be an important asthma management strategy. More research documenting effectiveness of interventions to reduce those exposures and improve asthma outcomes is needed. Figure 5 . Recent asthma symptoms and rescue medication use among mouse-sensitized, highly exposed children. Adjusted for age, sex, atopy, cockroach sensitization and exposure, public health insurance, and study visit. Figure 6 . Asthma health care use among mouse-sensitized, highly exposed children adjusted for age, sex, atopy, cockroach sensitization and exposure, public health insurance, and study visit.
